XPost: sci.med.diseases.cancer, talk.politics.guns, alt.fan.rush-limbaugh   
   XPost: sac.politics   
   From: edge@fullerton.edu   
      
   A recent drug trial administered to a handful of cancer patients had the   
   surprising result of eliminating the disease in every participant   
   involved.   
      
   The study was conducted on 18 rectal cancer patients at Memorial Sloan   
   Kettering Cancer Center in Manhattan and had a 100 percent success rate,   
   according to a paper published Sunday in the New England Journal of   
   Medicine.   
      
   “I believe this is the first time this has happened in the history of   
   cancer,” Dr. Luis A. Diaz Jr, the author of the paper, told the New York   
   Times.   
      
   The drug, dostarlimab, was administered to each patient every 3 weeks for   
   6 months.   
      
   The drug trial was expected to be followed by chemotherapy and surgery, as   
   is standard, for every participant.   
      
   Some patients may have even required surgery leading to bowel and urinary   
   dysfunction — or be forced to use a colostomy bag due to treatment, the   
   Times said.   
      
   However, since all patients had no evidence of a tumor after taking an   
   MRI, rectal examination or a biopsy they were spared the agony of   
   potentially damaging treatment.   
      
   “There were a lot of happy tears,” Dr. Andrea Cercek, an oncologist at   
   Memorial Sloan Kettering Cancer Center told the Times.   
      
   In addition to not needing further treatment, there were no instances of a   
   recurrence of cancer in the patients during follow-up appointments from 6   
   to 25 months after the trial ended.   
      
   One participant, Sascha Roth, told the Times that she planned to move to   
   Manhattan for chemotherapy and radiation treatment.   
      
   Then doctors gave her the good news — the trial worked and she was cancer-   
   free.   
      
   “I told my family,” Roth said. “They didn’t believe me.”   
      
   https://nypost.com/2022/06/06/every-cancer-patient-enters-remission-after-   
   drug-trial/   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)